Latest market price
16.45
+0.22+1.36%
CYRXQT64Cryoport, Inc.·NASDAQ
16.45+1.36%
TA
Loading chart...
Screen all →
Snapshot
Index—P/E—EPS (ttm)-0.82Insider Own12.15%Shs Outstand50.65MPerf Week-8.77%
Market Cap822.03MForward P/E—EPS next Y-0.65Insider Trans-4.17%Shs Float45.95MPerf Month-6.88%
Enterprise Value653.03MPEG—EPS next Q-0.19Short Float5.51%Perf Quarter6.64%
Income-36.00MP/S4.42EPS this Y-157.48%Short Ratio4.03Perf Half Y58.96%
Sales186.00MP/B1.67EPS next Y—ROA-4.80%Short Interest2.53MPerf YTD69.06%
Book/sh9.69P/C2.07EPS next 5Y—ROE-7.25%52W High18.88 -12.87%Perf Year80.33%
Cash/sh7.84P/FCF—EPS past 3/5Y—ROIC-5.46%52W Low7.61 116.16%Perf 3Y64.27%
Dividend Est.—EV/EBITDA—Sales past 3/5Y-7.59% 17.38%Gross Margin47.08%Volatility5.10% 4.39%Perf 5Y-79.36%
Dividend TTM—EV/Sales3.51EPS Y/Y TTM-161.65%Oper. Margin-21.25%ATR (14)0.77Perf 10Y786.89%
Dividend Ex-Date—Quick Ratio1.98Sales Y/Y TTM-8.37%Profit Margin-19.45%RSI (14)40.15Recom2.21
Dividend Gr. 3/5Y—Current Ratio2.08EPS Q/Q31.03%SMA20-7.03%Beta1.85Target Price20.19
Payout0.00%Debt/Eq0.46Sales Q/Q8.89%SMA50-4.19%Rel Volume1.48Prev Close16.23
Employees688LT Debt/Eq0.09EarningsNov 05SMA20021.77%Avg Volume682.43KPrice16.45
IPO DateAug 22, 2005Option/ShortYes / YesEPS/Sales Surpr.-3.45% 1.65%Net Debt/EBITDA—Volume1,009,810Change1.36%
Analyst Ratings
DateActionAnalystRatingTarget
Oct-13-26ReiteratedRobert W. Baird$26
Oct-13-26ReiteratedBTIGBuy$25 → $26
Oct-01-26ReiteratedGuggenheimBuy$16 → $19
Aug-07-26ReiteratedRoth CapitalBuy$15 → $21
Aug-07-26ReiteratedNeedhamBuy$15 → $19
Aug-07-26ReiteratedGuggenheimBuy$12 → $16
Jul-24-26ReiteratedBTIGBuy$17 → $25
Jun-08-26ReiteratedJefferiesHold$11 → $14
Jun-03-26ReiteratedCraig-HallumBuy$20
May-20-26ReiteratedKeybancOverweight$52 → $17
Latest News· Times ET
Oct-29-26
Oct-22-26
Oct-13-26
Oct-01-26
Sep-24-26
Sep-18-26
Aug-11-26
Aug-07-26
Aug-06-26
Aug-06-2609:04PM
Aug-04-26
Jul-27-26
Jul-24-26
Jul-23-26
Company

Cryoport, Inc. operates as a specialized service provider within the life sciences sector, delivering global temperature-controlled supply chain solutions across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Central to their offerings is Cryoportal, a proprietary cloud-based platform designed to streamline the entire logistics process. This robust system facilitates order processing, generates necessary documentation (including customs paperwork), coordinates courier services, offers real-time shipment tracking and monitoring, aids in issue resolution, and ensures adherence to regulatory compliance standards. To guarantee the integrity of sensitive materials during transit, Cryoport provides CryoPort Express Shippers, engineered to maintain the stability of biological commodities throughout their journey. Furthermore, their SmartPak Condition Monitoring System collects vital environmental data, which is then utilized to produce informative dashboards and essential validation reports for each shipment. Their product range also includes specialized containment solutions such as vacuum insulated aluminum dewars and advanced cryogenic freezer systems. Beyond transportation, the company offers extensive biological specimen management services. These encompass cryopreservation storage and ongoing maintenance, meticulous archiving, continuous monitoring, precise tracking, and efficient receipt and delivery of samples. They also manage the transport of frozen biological specimens to and from client facilities and oversee the inbound and outbound flow of these critical materials. Additionally, Cryoport extends its expertise through comprehensive logistics support and management services, alongside short-term consulting in both logistics and engineering. The company primarily caters to the biopharmaceutical, animal health, and human reproductive medicine industries. Founded in 1999, Cryoport's headquarters are situated in Brentwood, Tennessee.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue186176233237—————
Cost of Goods Sold Incl. D&A9993134133—————
Gross Profit888399104—————
Selling, General and Administrative Excl. Other110103147120—————
Research and Development18171816—————
Other Operating Expense00490—————
Operating Income-40-37-115-32—————
Interest Expense3266—————
Unusual Expense
—————————
Non-Operating Income (Expense)117213—————
Net Income Before Taxes-31-32-99-35—————
Income Taxes2202—————
Consolidated Net Income-3678-100-37—————
Net Income From Continuing Operations-33-34-100-37—————
Net Income-3678-100-37—————
EPS (Recurring)-0.821.40-2.21-0.93—————
EPS (Basic, Before Extraordinaries)-0.821.40-2.21-0.93—————
EPS (Diluted)-0.821.40-2.21-0.93—————
EBITDA-3-2-63-1—————
Other After Tax Adjustments
—————————
Stock Option Compensation Expense
—————————
Price To Earnings Ratio—6.86———————
Price To Sales Ratio4.422.731.643.20—————
Gross Margin47.3147.1642.4943.88—————
Operating Margin-21.51-21.02-49.36-13.50—————
Net Margin-19.3544.32-42.92-15.61—————
Shares Outstanding50504949—————
Market Capitalization823480381759—————
Operating Lease Expense
—————————
Unlock full historical data
See years of past statements with Premium.
Unlock with Premium
Insider Trading Volume
$20.28$16.73$13.18$9.63$6.08● Close Price0.00M0.91M1.81M2.72M3.62MUSD Trades VolumeNovDec2026FebMarAprMayJunJulAugSepOctNov
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
SHELTON JERRELLPresident, CEOAug 11 '26Sale14.9128,800429,3851,201,814Aug 11
ZECCHINI EDWARD JChief Digital and Tech OfficerJun 11 '26Sale14.4733,600486,239109,719Jun 12
ZECCHINI EDWARD JChief Digital and Tech OfficerJun 11 '26Option Exercise4.8033,600161,280143,319Jun 12
ZECCHINI EDWARD JChief Digital and Tech OfficerJun 10 '26Sale15.231,40021,324109,719Jun 12
ZECCHINI EDWARD JChief Digital and Tech OfficerJun 10 '26Option Exercise4.801,4006,720111,119Jun 12
Mandalam RamkumarDirectorJun 08 '26Sale15.4423,214358,45267,894Jun 08
STEFANOVICH ROBERTChief Financial OfficerJun 04 '26Sale16.27169,4272,756,984109,850Jun 08
SHELTON JERRELLPresident, CEOApr 21 '26Option Exercise1.87104,007194,4931,230,614Apr 23
SHELTON JERRELLPresident, CEOApr 06 '26Option Exercise1.8750,00093,5001,126,607Apr 08
SHELTON JERRELLPresident, CEOMar 23 '26Sale8.182,89423,6731,051,607Mar 25
STEFANOVICH ROBERTChief Financial OfficerMar 23 '26Sale8.181,0948,949279,277Mar 25
Sawicki Mark WChief Scientific OfficerMar 23 '26Sale8.181,34110,969102,356Mar 25
SHELTON JERRELLPresident, CEOMar 23 '26Option Exercise1.8725,00046,7501,076,607Mar 25
SHELTON JERRELLPresident, CEOMar 16 '26Sale8.007,91863,3441,054,501Mar 17
ZECCHINI EDWARD JOfficerMar 16 '26Sale8.002,01416,112109,719Mar 17
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.